Zynerba Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Zynerba Pharmaceuticals's balance sheet done over the years? Its assets were worth $55,520,894 last year, which is less than in the previous period. 17% of Zynerba Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $9,292,137, which means an decrease by -9% compared compared to last year.
Debt to Assets
| 2013 | 1860840 | 3.05M | 164.31% |
|---|---|---|---|
| 2014 | 11616671 | 19.66M | 169.31% |
| 2015 | 43643541 | 3.93M | 9.02% |
| 2016 | 36554274 | 6.96M | 19.06% |
| 2017 | 69054309 | 8.10M | 11.74% |
| 2018 | 67327443 | 9.72M | 14.45% |
| 2019 | 87764596 | 12.16M | 13.86% |
| 2020 | 74056776 | 13.91M | 18.79% |
| 2021 | 81171507 | 10.25M | 12.64% |
| 2022 | 55520894 | 9.29M | 16.74% |
ZYNE Balance Sheet (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 50.64M | 67.80M | 59.15M | 70.06M | 59.76M | 62.51M | 30.96M | 41.51M | 9.33M | 154.69K |
Short term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net receivables | 1.22M | 9.58M | 9.04M | 14.61M | 3.44M | 0 | 3.61M | 0 | 0 | 34.51K |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.49M | 0 | 0 |
Other current assets | 2.90M | 2.83M | 5.16M | 2.37M | 3.74M | 5.71M | 1.83M | 1.90M | 1.08M | 0 |
Total current assets | 54.77M | 80.21M | 73.36M | 87.05M | 66.95M | 68.22M | 36.41M | 43.41M | 11.59M | 689.27K |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 745.78K | 951.64K | 690.60K | 708.57K | 371.96K | 164.52K | 143.38K | 227.64K | 19.64K | 47.79K |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 0 | 0 | 0 | 0 | 0 | 662.2K | 200 | 200 | 2.2K | 1.12M |
Total non-current assets | 745.78K | 951.64K | 690.60K | 708.57K | 371.96K | 826.72K | 143.58K | 227.84K | 21.84K | 1.17M |
Total assets | 55.52M | 81.17M | 74.05M | 87.76M | 67.32M | 69.05M | 36.55M | 43.64M | 11.61M | 1.86M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 0 | 0 | 0 | 171.97K | 833.97K | 841.22K | 1.12M | 1.04M |
Short term debt | 214.90K | 209.06K | 109.68K | 243.67K | 0 | 0 | 0 | 0 | 0 | 125K |
Total current liabilities | 9.17M | 9.90M | 13.91M | 12.05M | 9.72M | 7.44M | 6.96M | 3.93M | 3.14M | 1.56M |
| Non-current liabilities: | ||||||||||
Long term debt | 119.52K | 353.69K | 0 | 109.68K | 0 | 0 | 0 | 0 | 0 | 374.99K |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total non-current liabilities | 119.52K | 353.69K | 0 | 109.68K | 0 | 662K | 0 | 0 | 16.52M | 1.49M |
Total liabilities | 9.29M | 10.25M | 13.91M | 12.16M | 9.72M | 8.10M | 6.96M | 3.93M | 19.66M | 3.05M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |